Tenaya Therapeutics Reports Q2 2026 Financial Results

What Happened Tenaya Therapeutics announced its financial results for the quarter ended June 30, 2026 by issuing an earnings press release on August 5, 2026. The company furnished the full text of that press release as Exhibit 99.1 to an 8-K (Item 2.02), incorporating the release by reference into the filing.

Key Details

• Filing date: August 5, 2026 (Form 8-K, Item 2.02).
• Reporting period: quarter ended June 30, 2026 (Q2 2026).
• Exhibit: Earnings Press Release is attached as Exhibit 99.1 and is incorporated by reference.
• Legal note: The press release and related exhibits are furnished (not “filed”) and thus are not deemed filed for purposes of Section 18 of the Exchange Act and are not automatically incorporated by reference in other filings.

Why It Matters Earnings press releases provide the company’s latest quarterly performance data (revenue, expenses, cash position, and any management commentary). Investors should review Exhibit 99.1 for the specific financial figures and any forward-looking statements or guidance. The filing’s “furnished, not filed” status affects legal treatment (limited Section 18 liability) and means the release won’t be automatically incorporated into other SEC filings unless explicitly referenced.